Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms Compound [11C]8(Virginia Commonwealth University) |
Target |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC18H16ClN3O3 |
InChIKeyXUBLPAZNPKXTRN-BJUDXGSMSA-N |
CAS Registry3057114-26-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Discovery | United States | 27 Dec 2023 |